Correlation Between GlaxoSmithKline PLC and Mfs Emerging
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Mfs Emerging at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Mfs Emerging into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Mfs Emerging Markets, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Mfs Emerging and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Mfs Emerging. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Mfs Emerging.
Diversification Opportunities for GlaxoSmithKline PLC and Mfs Emerging
0.67 | Correlation Coefficient |
Poor diversification
The 3 months correlation between GlaxoSmithKline and Mfs is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Mfs Emerging Markets in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mfs Emerging Markets and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Mfs Emerging. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mfs Emerging Markets has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Mfs Emerging go up and down completely randomly.
Pair Corralation between GlaxoSmithKline PLC and Mfs Emerging
Considering the 90-day investment horizon GlaxoSmithKline PLC is expected to generate 1.47 times less return on investment than Mfs Emerging. In addition to that, GlaxoSmithKline PLC is 2.73 times more volatile than Mfs Emerging Markets. It trades about 0.01 of its total potential returns per unit of risk. Mfs Emerging Markets is currently generating about 0.05 per unit of volatility. If you would invest 483.00 in Mfs Emerging Markets on August 26, 2024 and sell it today you would earn a total of 56.00 from holding Mfs Emerging Markets or generate 11.59% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
GlaxoSmithKline PLC ADR vs. Mfs Emerging Markets
Performance |
| Timeline |
| GlaxoSmithKline PLC ADR |
| Mfs Emerging Markets |
GlaxoSmithKline PLC and Mfs Emerging Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GlaxoSmithKline PLC and Mfs Emerging
The main advantage of trading using opposite GlaxoSmithKline PLC and Mfs Emerging positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Mfs Emerging can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mfs Emerging will offset losses from the drop in Mfs Emerging's long position.| GlaxoSmithKline PLC vs. Novartis AG ADR | GlaxoSmithKline PLC vs. AstraZeneca PLC ADR | GlaxoSmithKline PLC vs. Roche Holding Ltd | GlaxoSmithKline PLC vs. Bristol Myers Squibb |
| Mfs Emerging vs. Franklin Growth Opportunities | Mfs Emerging vs. Mid Cap Growth | Mfs Emerging vs. Ab Centrated Growth | Mfs Emerging vs. Qs Moderate Growth |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |